Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 4 studies | 23% ± 8% | |
epithelial cell | 3 studies | 23% ± 4% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of BET1L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2882.20 | 1445 / 1445 | 100% | 39.34 | 183 / 183 |
kidney | 100% | 3422.79 | 89 / 89 | 100% | 46.93 | 901 / 901 |
liver | 100% | 2645.89 | 226 / 226 | 100% | 33.18 | 406 / 406 |
pancreas | 100% | 4127.01 | 328 / 328 | 100% | 47.61 | 178 / 178 |
prostate | 100% | 4371.47 | 245 / 245 | 100% | 61.04 | 502 / 502 |
skin | 100% | 3487.66 | 1809 / 1809 | 100% | 49.21 | 472 / 472 |
stomach | 100% | 3139.58 | 359 / 359 | 100% | 42.29 | 286 / 286 |
thymus | 100% | 3878.36 | 653 / 653 | 100% | 52.29 | 605 / 605 |
lung | 100% | 3422.11 | 578 / 578 | 100% | 43.09 | 1154 / 1155 |
intestine | 100% | 3497.12 | 966 / 966 | 100% | 45.60 | 526 / 527 |
uterus | 100% | 3902.02 | 170 / 170 | 100% | 34.50 | 458 / 459 |
ovary | 100% | 4413.86 | 180 / 180 | 100% | 35.23 | 429 / 430 |
adrenal gland | 100% | 3396.11 | 258 / 258 | 100% | 40.29 | 229 / 230 |
breast | 100% | 3577.77 | 459 / 459 | 99% | 53.42 | 1112 / 1118 |
bladder | 100% | 3590.76 | 21 / 21 | 99% | 38.49 | 501 / 504 |
brain | 99% | 1753.81 | 2628 / 2642 | 100% | 28.87 | 704 / 705 |
adipose | 100% | 3297.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3941.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 52.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.70 | 29 / 29 |
spleen | 100% | 3686.82 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.63 | 1 / 1 |
heart | 99% | 1962.86 | 856 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1226.53 | 790 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 29.50 | 44 / 45 |
peripheral blood | 98% | 2415.94 | 906 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0061025 | Biological process | membrane fusion |
GO_0015031 | Biological process | protein transport |
GO_2000156 | Biological process | regulation of retrograde vesicle-mediated transport, Golgi to ER |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005768 | Cellular component | endosome |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031201 | Cellular component | SNARE complex |
GO_0016020 | Cellular component | membrane |
GO_0005484 | Molecular function | SNAP receptor activity |
Gene name | BET1L |
Protein name | BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15) BET1-like protein Bet1 golgi vesicular membrane trafficking protein like |
Synonyms | GS15 |
Description | FUNCTION: Vesicle SNARE required for targeting and fusion of retrograde transport vesicles with the Golgi complex. Required for the integrity of the Golgi complex (By similarity). . FUNCTION: Vesicle SNARE required for targeting and fusion of retrograde transport vesicles with the Golgi complex. Required for the integrity of the Golgi complex. . FUNCTION: Vesicle SNARE required for targeting and fusion of retrograde transport vesicles with the Golgi complex. Required for the integrity of the Golgi complex. . |
Accessions | ENST00000486280.1 ENST00000410108.5 Q9NYM9 ENST00000529614.6 E9PHY4 E9PQJ6 B8ZZS0 ENST00000332865.10 ENST00000382762.8 A0A0C4DH16 H7BXT7 ENST00000325147.13 |